While studies directly examining the role of TLSs in ESCC remain limited, accumulating evidence indicates that TLSs are robust predictors of ICI efficacy in several tumor types, independent of PD-L1 expression status (28). This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.